Search alternatives:
significant effects » significant effect (Expand Search), significantly affected (Expand Search)
effects decrease » effects decreased (Expand Search), effects regress (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
significant effects » significant effect (Expand Search), significantly affected (Expand Search)
effects decrease » effects decreased (Expand Search), effects regress (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
-
61
-
62
-
63
-
64
-
65
Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
66
Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
67
Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
68
Loxoprofen and SB225002 administration decreased sound stress exposure-induced hyperalgesia.
Published 2025“…<p>The nociceptive test assessed the effects of analgesics after sound exposure. Mice exposed to sound stress and treated with saline (Stress + saine group) showed significantly increased response times to the filament compared to the control (non-stress) group (0 − 30 min after administration, <sup>#</sup><sup>###</sup><i>P</i> < 0.0001; Bonferroni test). …”
-
69
-
70
-
71
-
72
-
73
-
74
-
75
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
76
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
77
-
78
-
79
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
80
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: